NYSEARCA:MRNY YieldMax MRNA Option Income Strategy ETF (MRNY) Price, Holdings, & News $2.46 -0.06 (-2.38%) Closing price 04:10 PM EasternExtended Trading$2.47 +0.01 (+0.41%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipBuy This Stock About YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MRNY alerts:Sign Up Key Stats Today's Range$2.34▼$2.5250-Day Range$2.46▼$4.9552-Week Range$2.35▼$22.37Volume1.53 million shsAverage Volume536,169 shsMarket Capitalization$59.66 millionAssets Under Management$64.95 millionDividend Yield234.15%Net Expense Ratio0.99%Aggregate RatingN/A ETF OverviewThe YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.Read More… Remove Ads YieldMax MRNA Option Income Strategy ETF ExpensesTypeMRNYSingle Stock ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.99%0.95%0.56%0.51%0.53%Other Expenses0.00%0.35%0.49%0.57%0.52%Total Expense0.99%1.16%0.72%0.73%0.71%Fee Waiver0.00%-0.32%-0.50%-0.66%-0.55%Net Expense0.99%1.04%0.63%0.58%0.60% Receive MRNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for YieldMax MRNA Option Income Strategy ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address MRNY ETF News HeadlinesYieldMax MRNA Option Income Strategy ETF (MRNY) Dividend HistoryMarch 30, 2025 | nasdaq.comYieldMax PLTR Option Income Strategy ETF declares $5.9377 dividendFebruary 27, 2025 | msn.comNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. April 4, 2025 | Porter & Company (Ad)YieldMax MRNA Option Income Strategy ETF declares $1.131 dividendMarch 6, 2024 | msn.comMRNA Mar 2024 114.000 callFebruary 29, 2024 | sg.finance.yahoo.comMRNY Mar 2024 19.000 callFebruary 23, 2024 | finance.yahoo.comSee More Headlines MRNY ETF - Frequently Asked Questions How have MRNY shares performed this year? YieldMax MRNA Option Income Strategy ETF's stock was trading at $5.26 at the start of the year. Since then, MRNY stock has decreased by 53.2% and is now trading at $2.46. View the best growth stocks for 2025 here. How do I buy shares of YieldMax MRNA Option Income Strategy ETF? Shares of MRNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of YieldMax MRNA Option Income Strategy ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that YieldMax MRNA Option Income Strategy ETF investors own include YieldMax NVDA Option Income Strategy ETF (NVDY), YieldMax COIN Option Income Strategy ETF (CONY), YieldMax META Option Income Strategy ETF (FBY), Defiance Nasdaq 100 Enhanced Options & 0DTE Income ETF (QQQY), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Oxford Lane Capital (OXLC) and YieldMax AMZN Option Income Strategy ETF (AMZY). Fund Details IssuerElevate Shares Fund NameYieldMax MRNA Option Income Strategy ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:MRNY Inception Date10/23/2023 Fund ManagerMick Brokaw, Jay Pestrichelli, Qiao Duan, Charles Ragauss WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusSingle Stock Development LevelDeveloped Markets RegionNorth America Number of Holdings11 Fund Statistics Assets Under Management$64.95 million Average Daily Volume$0.00 Discount/Premium0.01% Administrator, Advisor and Custodian AdministratorTidal ETF Services LLC AdvisorToroso Investments, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerCitadel Options OptionableOptionable Options Volume311 Put Options310 Call Options1 Short Interest314,200 shs Miscellaneous Outstanding Shares24,250,000Beta0.98 Creation Fee$300.00 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report Top 10 MRNY HoldingsUnited States Treasury Notes 3%Holding Weight: 25.87%United States Treasury Notes 3.88%Holding Weight: 25.82%MRNA US 05/16/25 C35Holding Weight: 21.90%United States Treasury Notes 2.63%Holding Weight: 16.87%United States Treasury Bills 0%Holding Weight: 16.34%United States Treasury Bills 0%Holding Weight: 12.56%MRNA US 03/21/25 C40.5Holding Weight: 4.10%United States Treasury Bills 0%Holding Weight: 3.32%DEPOSITS WITH BROKER FOR SHORT POSITIONSHolding Weight: 1.97%Cash OffsetHolding Weight: 0.14%Full Holdings Details This page (NYSEARCA:MRNY) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YieldMax MRNA Option Income Strategy ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share YieldMax MRNA Option Income Strategy ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.